Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
110 hedge funds and large institutions have $445M invested in Intersect ENT, Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 19 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 31
0% more call options, than puts
Call options by funds: $950K | Put options by funds: $950K
4% less funds holding
Funds holding: 115 → 110 (-5)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
16% less capital invested
Capital invested by funds: $528M → $445M (-$82.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.7M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$3.59M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.83M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.5M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$11.5M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$2.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.53M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
-$2.52M |
| 5 |
VAM
Visium Asset Management
New York
|
-$2.25M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
BNP Paribas Financial Markets
Paris,
France
| – | -$75.2K | -3,340 | Closed |
|
|
PCM
127
Prelude Capital Management
New York
| – | -$42K | -1,855 | Closed |
|
|
CSS
128
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$21K | -928 | Closed |
|
|
HNB
129
Huntington National Bank
Columbus,
Ohio
| – | -$1K | -49 | Closed |
|
XENT Hedge Fund Activity: Q1 2016 in Review
110 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2016, worth a combined $445M — down 16% from $528M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of XENT and 17 opened new positions — a net loss of 2 holders — while 31 trimmed existing stakes and 39 added.
The largest buyer was Federated Hermes, adding an estimated $16.7M. The largest seller was Allianz Asset Management, cutting an estimated $11.5M.
- 110 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2016, down from 115 in Q4 2015.
- Funds reported $445M of Intersect ENT, Inc stock for Q1 2016, down 16% quarter-over-quarter.
- 17 funds opened new Intersect ENT, Inc positions in Q1 2016 and 19 closed out, a net change of -2 holders.
- The largest Intersect ENT, Inc buyer in Q1 2016 was Federated Hermes, an estimated $16.7M added.
- The largest Intersect ENT, Inc seller in Q1 2016 was Allianz Asset Management, an estimated $11.5M sold.
Based on aggregated 13F filings for Q1 2016.